Salidroside may reduce liver scarring from fatty liver disease by controlling cell cleanup through the PI3K/AKT/mTOR pathway

Salidroside (SAL) may be effective against fibrosis induced by MASH.

• SAL is the primary active compound derived from Rhodiola rosea.
• The exact pharmacological mechanisms of SAL are not fully understood.
• SAL may target specific molecular pathways related to fibrosis.
• Further research is needed to clarify SAL's efficacy and mechanisms.

Simplified